Related Videos
Alex Niu of Roswell Park Comprehensive Cancer Center and Matthew Mei from City of Hope discuss changes and challenges in the treatment of Hodgkin lymphoma.
With a focus on immunotherapy, CAR T-cell therapy and bispecific treatments, Dr. Niu believes a more direct, targeted approach will become the gold standard for leukemia and other diseases in the near future, offering patients a better quality of life.